CTRC RES FOUNDATION has a total of 13 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, organic fine chemistry and machines are ENTEROME, NANJING PRACTICE MEDICINE EXAMINATION CO LTD and SHANGHAI TISSUEBANK BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Unspecified technologies | |
#3 | Medical preparations | |
#4 | Heterocyclic compounds | |
#5 | Sugars | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Windle Bradford E | 8 |
#2 | Chen Shih-Fong | 7 |
#3 | Fletcher Terace M | 5 |
#4 | Maine Ira | 4 |
#5 | Qiu Ming | 3 |
#6 | Meltzer Paul | 3 |
#7 | Trent Jeffrey | 3 |
#8 | Mcgill John | 3 |
#9 | Von Hoff Daniel | 2 |
#10 | Weis Alexander L | 2 |
Publication | Filing date | Title |
---|---|---|
US6004939A | Methods for modulation and inhibition of telomerase | |
US5856096A | Rapid and sensitive assays for detecting and distinguishing between processive and non-processive telomerase activities | |
AU3214995A | Bis-naphthalimides with linkers having heteroatoms and uses thereof | |
US5658730A | Methods of human prostate cancer diagnosis | |
US6638715B1 | Methods and compositions for extended and super-extended DNA and hybridization mapping | |
WO9416104A1 | Color imaging system for use in molecular biology |